ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Family Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

15,473Medicare Part D Prescriptions Filled, Including Refills

Rank: 124 out of 2170

$761K Total Retail Price of All Prescriptions

Rank: 171 out of 2170

786 Patients Receiving at Least One Drug in Part D
87%Patients 65 Years and Older
24% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in North Carolina
Lower avg

Schedule Two
Controlled Substances

4% of this provider’s 786 patients filled at least one prescription for a schedule two drug, compared to an average of 6%.

Schedule Three
Controlled Substances

7% of this provider’s 786 patients filled at least one prescription for a schedule three drug, compared to an average of 11%.

Risky Drugs to Seniors

2% of this provider’s 13,941 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

25% of this provider’s prescriptions were for brand-name drugs, compared to an average of 25%.

Prescription Price

$49 was the average price of a prescription from this provider, compared to $57 among peers.

Prescriptions per Patient

20 is the average number of prescriptions (including refills) per patient, compared to an average of 21.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in North Carolina
AMLODIPINE BESYLATE 706 671 1 4
HYDROCHLOROTHIAZIDE 619 567 2 9
OMEPRAZOLE 554 492 3 2
PRAVASTATIN SODIUM 489 450 4 11
GLIMEPIRIDE 425 376 5 31
LISINOPRIL 408 374 6 3
ATORVASTATIN CALCIUM 389 365 7 12
METFORMIN HCL 383 333 8 8
METOPROLOL SUCCINATE 375 346 9 13
LEVOTHYROXINE SODIUM 358 340 10 5
SIMVASTATIN 355 297 11 1
LOSARTAN POTASSIUM 351 338 12 21
CRESTOR 330 315 13 24
METOPROLOL TARTRATE 310 282 14 10
HYDROCODONE-ACETAMINOPHEN 297 251 S3 15 7
POTASSIUM CHLORIDE 260 240 16 16
ZOLPIDEM TARTRATE 255 233 17 17
AMLODIPINE BESYLATE-BENAZEPRIL 247 212 18 67
FUROSEMIDE 231 202 19 6
WARFARIN SODIUM 207 197 20 15
RAMIPRIL 190 154 21 77
ATENOLOL 181 177 22 23
ALLOPURINOL 155 151 23 29
VERAPAMIL ER 148 128 24 94
CLOPIDOGREL 146 130 25 37
CITALOPRAM HBR 143 126 26 19
DONEPEZIL HCL 139 127 27 32
TAMSULOSIN HCL 138 138 28 33
SERTRALINE HCL 136 119 29 25
DIOVAN 135 127 30 53
QUINAPRIL HCL 131 128 31 117
NAMENDA 128 128 32 48
LIPITOR 126 119 33 83
BENAZEPRIL HCL 124 119 34 55
LOSARTAN-HYDROCHLOROTHIAZIDE 116 116 35 42
DILTIAZEM 24HR CD 113 109 36 82
RANITIDINE HCL 113 82 36 40
ALENDRONATE SODIUM 110 109 38 36
PLAVIX 109 91 39 58
DIOVAN HCT 104 93 40 76
PANTOPRAZOLE SODIUM 103 90 41 39
SPIRIVA 98 96 42 49
MELOXICAM 96 93 43 28
METFORMIN HCL ER 96 92 43 35
CARVEDILOL 88 84 45 26
PREDNISONE 86 74 46 41
GABAPENTIN 82 76 47 14
TRAMADOL HCL 81 73 48 18
CELEBREX 80 64 49 89
NEXIUM 76 76 50 22
KLOR-CON M10 74 72 51 132
DIGOXIN 73 62 52 72
LANTUS 72 58 53 51
CYCLOBENZAPRINE HCL 68 53 R 54 52
BISOPROLOL-HYDROCHLOROTHIAZIDE 66 66 55 116
AZITHROMYCIN 64 57 56 47
DILTIAZEM ER 64 49 56 133
GLYBURIDE 63 58 R 58 118
ISOSORBIDE MONONITRATE ER 63 63 58 50
CIPROFLOXACIN HCL 62 56 60 69
ESCITALOPRAM OXALATE 61 45 61 75
CYMBALTA 60 49 62 44
KLOR-CON 10 59 59 63 144
INSULIN SYRINGE 58 37 64 113
VENLAFAXINE HCL ER 57 42 65 97
LEVOXYL 56 52 66 115
CLONIDINE HCL 56 56 66 54
PROAIR HFA 54 36 68 43
FLUTICASONE PROPIONATE 53 52 69 30
LANTUS SOLOSTAR 50 50 70 79
ENALAPRIL MALEATE 50 43 70 64
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on July 8, 2007.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.